Context Mediates Antimicrobial Efficacy of Kinocidin Congener Peptide RP-1 by Yount, Nannette Y. et al.
Context Mediates Antimicrobial Efficacy of Kinocidin
Congener Peptide RP-1
Nannette Y. Yount1,2, Samuel E. Cohen1,2,3, Deborah Kupferwasser1,2, Alan J. Waring2,5,6,8, Piotr
Ruchala5, Shantanu Sharma7, Karlman Wasserman2,4, Chun-Ling Jung5, Michael R. Yeaman1,2,5,8*
1Division of Infectious Diseases, Los Angeles County-Harbor University of California Los Angeles Medical Center, Torrance, California, United States of America, 2 Los
Angeles Biomedical Research Institute at Harbor-University of California Los Angeles Medical Center, Torrance, California, United States of America, 3 School of Medicine,
University of California Irvine, Irvine, California, United States of America, 4Division of Pulmonary / Critical Care Medicine, Los Angeles County-Harbor University of
California Los Angeles Medical Center, Torrance, California, United States of America, 5Department of Medicine, David Geffen School of Medicine at University of
California Los Angeles, Los Angeles, California, United States of America, 6Department of Physiology and Biophysics, School of Medicine, University of California Irvine,
Irvine, California, United States of America, 7Materials and Process Simulation Center, California Institute of Technology, Pasadena, California, United States of America,
8Division of Molecular Medicine, Los Angeles County-Harbor University of California Los Angeles Medical Center, Torrance, California, United States of America
Abstract
Structure-mechanism relationships are key determinants of host defense peptide efficacy. These relationships are influenced
by anatomic, physiologic and microbiologic contexts. Structure-mechanism correlates were assessed for the synthetic
peptide RP-1, modeled on microbicidal domains of platelet kinocidins. Antimicrobial efficacies and mechanisms of action
against susceptible (S) or resistant (R) Salmonella typhimurium (ST), Staphylococcus aureus (SA), and Candida albicans (CA)
strain pairs were studied at pH 7.5 and 5.5. Although RP-1 was active against all study organisms, it exhibited greater
efficacy against bacteria at pH 7.5, but greater efficacy against CA at pH 5.5. RP-1 de-energized SA and CA, but caused
hyperpolarization of ST in both pH conditions. However, RP-1 permeabilized STS and CA strains at both pH, whereas
permeabilization was modest for STR or SA strain at either pH. Biochemical analysis, molecular modeling, and FTIR
spectroscopy data revealed that RP-1 has indistinguishable net charge and backbone trajectories at pH 5.5 and 7.5. Yet,
concordant with organism-specific efficacy, surface plasmon resonance, and FTIR, molecular dynamics revealed modest
helical order increases but greater RP-1 avidity and penetration of bacterial than eukaryotic lipid systems, particularly at
pH 7.5. The present findings suggest that pH– and target–cell lipid contexts influence selective antimicrobial efficacy and
mechanisms of RP-1 action. These findings offer new insights into selective antimicrobial efficacy and context–specificity of
antimicrobial peptides in host defense, and support design strategies for potent anti-infective peptides with minimal
concomitant cytotoxicity.
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Introduction
Host defense effector molecules such as antimicrobial peptides
are key contributors to first line defense against invading
microorganisms. Presently, over 3,000 naturally-occurring cationic
antimicrobial peptides have been isolated from organisms spanning
the evolutionary continuum [1,2]. Structurally, such peptides can be
divided into two major groups: 1) linear / extended peptides
predominantly of a-helical conformation; and 2) disulfide-contain-
ing peptides that largely exhibit b-sheet structures [1,2]. Mecha-
nisms of antimicrobial efficacy of host defense peptides can be
generalized to involve three complementary modes: cytoplasmic
membrane permeabilization, cytoplasmic membrane (bacterial) or
mitochondrial (eukaryotic pathogen) de-energization, and inhibi-
tion of macromolecular synthesis (e.g. cell wall, nucleic acid) or
essential pathways [2]. Such mechanisms are believed to involve
initial peptide targeting based on electrostatic and hydrophobic
interactions, followed by structural or functional organization of the
peptide upon or within target cell or organelle membranes [3].
Host defense peptides interact with pathogens in distinct
anatomic and physiologic settings. It follows that specific peptides
have evolved for optimal function in respective host contexts
against cognate pathogens. For example, neutrophil phagolyso-
somes or other inflammatory contexts exhibit acidic pH of 4.5 to
6.5 [4]. In contrast, the bloodstream and mucosal surfaces
maintain neutral pH of 7.2 to 7.5 [5]. We hypothesize that host
anatomic, physiologic, and microbiologic contexts shape peptide
selective efficacy or immunomodulatory functions in situ [1,6,7,8].
These conditional factors likely influence peptide selectivity for
specific cell targets, such as anionic versus zwitterionic phospho-
lipids, and prokaryotic versus eukaryotic differences in transmem-
brane potential (DY) [2].
Beyond fundamental characterization of a peptide, investigating
its interactions with target pathogens provides new opportunities
to understand specific mechanisms of action and selective toxicity.
In the current investigation, this approach was integrated to assess
the impact of pH and lipid context on pathogen-specific and
structure-mechanism relationships of the synthetic anti-infective
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candidate peptide RP-1 against prototypical Gram-positive,
Gram-negative, and fungal pathogens. The current studies were
designed to address the hypothesis that pH and/or target cell-
specific contexts, alone or in combination, impact antimicrobial
peptide selectivity and efficacy.
Results
Influence of pH on RP-1 Antimicrobial Specificity
RP-1 exerted potent efficacy against ST, SA and CA under one
or more experimental conditions (Table 1; also see Table S1).
However, several functional correlates were observed reflecting
pH and organism specificity. For example, RP-1 efficacy was
greatest overall against bacteria at pH 7.5. Interestingly, RP-1 had
equivalent efficacy against ST and SA strains at pH 7.5, with no
significant differences between respective S and R strains in this
condition. In contrast, pH 5.5 conditions disclosed significant
differences in RP-1 efficacy against the S and R phenotypes of ST
and SA strains. Moreover, RP-1 exerted greatest anti-candidal
efficacy at pH 5.5. There were no detectable differences in RP-1
susceptibility of the CAS and CAR strains at a given pH value.
Therefore, RP-1 target organism selectivity and efficacy were
distinctive as a function of pH.
Influence of pH and Target Cell Specificity on RP-1
Mechanisms of Action
As a complement to efficacy data, the impact of pH and target
specificity was studied for two comparative mechanisms of RP-1:
membrane permeabilization (MP) and DY (Figure 1; also see
Figure S1).
RP-1 vs. S. typhimurium
The ST study strains are known to differ in DY, conferring
distinct susceptibility profiles to certain cationic peptides. Consis-
tent with this relationship, basal membrane DY was reduced for
STR versus STS (Figure 1A). Flow cytometry corroborated
significant RP-1 efficacy against ST strains at pH 7.5. RP-1
exerted virtually complete MP of STS at pH 7.5 or 5.5, but modest
MP of STR at pH 7.5, and minimal MP at pH 5.5 (Figure 1B).
Interestingly, RP-1 exposure led to increased DY (hyperpolariza-
tion) of both ST strains at pH 7.5, but only the STR strain at
pH 5.5 (Figure 1C).
RP-1 vs. S. aureus
Present studies revealed that the basal DY of the SAR strain was
lower than its SAS counterpart, consistent with prior findings
(Figure 1A; [9]). RP-1 exposure led to alterations in DY and
permeabilization in SA that differed from those for ST. For
example, RP-1 induced minimal MP of either SA strain at pH 5.5
or 7.5 over 1 h exposure (Figure 1B). Nonetheless, RP-1-induced
depolarization of SA strains was equivalent under either pH
condition over the assay period (Figure 1C).
RP-1 vs. C. albicans
RP-1-induced permeabilization of CA strains was significant
and equivalent at pH 5.5. as well as 7.5 (Figure 1B). In contrast,
depolarization was minimal for either CA strain at either pH
(Figure 1C) over the time period evaluated.
Influence of pH on RP-1 Physicochemistry
Given the differences observed in RP-1 target organism
selectivity and efficacy as a function of pH, potential effects of
pH on RP-1 physicochemistry were assessed. RP-1 has a net
charge of +7.7 at pH 7.5, with a partial charge increase
calculated to +8.0 at pH 5.5 (Table 2). Based on its NMR-
determined 3-D structure, RP-1 conforms to a highly-ordered
amphipathic a-helix [10] Figure 2A). Such a conformation
segregates electrostatic charge and hydrophobicity to relative
contralateral facets of the peptide, yielding a polar angle of 178.6u
(Figure 2B). At pH 7.5, the calculated mean hydrophobic
moment (MH) for RP-1 is 0.66, with a net hydrophobicity of
21.45. No distinct impact of pH 5.5 on these parameters of RP-1
was detected in the current studies.
Influence of pH and Target Lipid Context on RP-1
Structure-Activity Relationships
To integrate pH and target lipid context influences on RP-1
structure-activity relationships, multiple and complementary
approaches were used to compare peptide secondary structure
and orientation in mimetic liposome systems reflecting bacterial
and eukaryotic membrane systems [11]. Several key findings
emerged from these investigations.
Influence of pH on RP-1 Affinity for Bacterial versus
Mammalian Lipid Systems
Kinetic interactions of RP-1 with membrane liposomes were
measured by two complementary methods. Importantly, surface
plasmon resonance (SPR) analysis demonstrated strongest associ-
ation between RP-1 and bacterial lipids at pH 7.5
(KD = 1.15610
27 M). By comparison, the affinity of RP-1 for
eukaryotic mimetic lipids was markedly reduced at this pH
(KD = 5.29610
27 M). Moreover, RP-1 also significantly associat-
ed with prokaryotic lipids at pH 5.5 (KD = 9.18610
28 M), while
there was no detectable interaction of RP-1 and eukaryotic lipids
at this pH (Table 3). In addition, the temporal association of RP-1
with lipid systems varied with pH. Interestingly, at pH 7.5 there
was a multi-phasic interaction between RP-1 and both target lipid
ensembles (Figure 3). In contrast, at pH 5.5 the association of
RP-1 with bacterial lipids was relatively mono-phasic, while it was
undetectable for eukaryotic lipids.
Binding Kinetics
Binding studies showed that RP-1 has significantly greater
affinity for prokaryotic than eukaryotic lipids, particularly at
pH 5.5 (Figure 3). In agreement with efficacy and SPR outcomes,
KA was greatest between RP-1 and bacterial large unilamellar
vesicles (LUVs) at pH 7.5 (Table 3). Moreover, KA was
significantly reduced for RP-1 with the same membrane lipids at
pH 5.5. Interestingly, the association between RP-1 and a
mammalian lipid system was minimal at pH 5.5. Overall, these
data are concordant with antimicrobial efficacy outcomes.
Table 1. Antimicrobial activity of RP-1 versus representative
ST, SA and CA sensitive and resistant pathogen strain pairs.
S. typhimurium S. aureus C. albicans
pH STS STR SAS SAR CAS CAR
5.5 14.060.7{ 8.860.4 7.060.9{ 3.860.4 9.160.3 8.960.9
7.5 15.560.4* 14.560.7* 13.360.8* 12.861.8* 6.163.2 6.662.9
Antimicrobial efficacy is measured as the zone of inhibition (millimeters) around
a central well. Significant differences (P values#0.05) within strain at pH 5.5
versus 7.5 ({); or between sensitive and resistant strains at constant pH (*).
doi:10.1371/journal.pone.0026727.t001
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Conformation
Conformation was measured using FTIR spectroscopy and
relative amounts of a-helix (1662–1645 cm21), b-sheet (1637–
1613 and 1710–1682 cm21), turn/bend (1682–1662 cm21), and
disordered or random (1650–1637 cm21) structures were estimat-
ed by Fourier self-deconvolution. Component peak areas were
calculated using curve fitting software. These analyses suggest that
RP-1 may be slightly more helical in bacterial mimetic lipids, with
52% helicity at pH 7.5 and 50% helicity at pH 5.5 (Table 3;
Figure S2). In contrast, in this mammalian lipid system, RP-1
exhibited less helical propensity, with 43% and 40% helicity at
pH 7.5 and 5.5 respectively. In each case, relative b-sheet
constituents reflected the modest differences corresponding to a-
helical content in the distinct lipid environments.
Angle of Insertion
The angle of RP-1 insertion in prokaryotic or eukaryotic
membrane systems was estimated by FTIR absorbance at 0u and
90u polarization (Table 3). These experiments indicated that the
greatest degree of helical tilt for RP-1 (51u) occurred in bacterial
lipid multilayers at pH 7.5. Reducing the pH to 5.5 yielded a 5u
reduction in the RP-1 helical tilt angle (46u). This difference in
insertion angle corresponded with the peptide spanning the bilayer
leaflet interface at pH 7.5, but not at pH 5.5 (see below). Notably,
the RP-1 helical tilt angle was markedly less acute (34u or 31u at
pH 7.5 or 5.5, respectively) upon peptide interaction with
zwitterionic, cholesterol containing membranes (Table 3).
Molecular Dynamics
As a complement to empirical studies of efficacy, conformation
and binding, in-silico studies of RP-1-lipid interactions were
performed by molecular dynamics using the initial NMR
(2RLG; [10]) structure consistent with conditions of pH 5.5.
Consistent with FTIR data, RP-1 penetrated the bacterial lipid
environment at a sharp angle (,48u) and was completely
embedded into the bilayer under these conditions (Figure 4).
Figure 1. Flow cytometric analysis of: (A) basal membrane electronegativity; and (B) membrane permeabilization or (C) energetics
for untreated and RP-1 treated cell populations at pH 7.5 and 5.5. (A) Basal membrane electronegativity (untreated stained cells) for
sensitive versus resistant ST and SA at pH 7.5 and 5.5. Comparison of membrane permeabilization (B) or energetics (C) between untreated (black) and
RP-1 treated microorganisms. RP-1 and Control panels (B,C) depict fluorescence (Y-axis) vs. FSC (forward scatter; size / granularity; X-axis) of individual
cells. Indicated values represent the percentage of cells that are beyond the control (black) area. Merged panel shows histogram analysis of: (B)
permeabilization - control (black) vs. RP-1 treated (red); or (C) energetics - control (black) vs. RP-1 treated (green). INT = intact cells;
PER =permeabilized cells; DEP= depolarized cells; HYP= hyperpolarized cells.
doi:10.1371/journal.pone.0026727.g001
Table 2. Sequence and biophysical properties of RP-1.
Calculated Charge at pH
Peptide Sequence MW pI 5.0 5.5 6.0 6.5 7.0 7.5
RP-1 A1LYKK5FKKKL10LKSLK15RLG18 2162.7 10.8 8.0 8.0 8.0 8.0 7.9 7.7
doi:10.1371/journal.pone.0026727.t002
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Moreover, this extent of lipid insertion was such that RP-1
spanned the outer-to-inner membrane leaflet interface. Further
corroborating the biophysical data, the degree of lipid penetration
was reduced in the bacterial lipid system at pH 5.5, with RP-1
restricted to the outer membrane leaflet. In marked contrast to
prokaryotic lipids, simulations for RP-1 in eukaryotic membrane
environments at pH 7.5 predicted little if any membrane
penetration, and no detectable interaction at pH 5.5 (Figure 4).
Under either pH condition, RP-1 assumed a predominantly
random coil conformation, and was restricted to the phospholipid-
water interface with little detectable lipid interaction.
To explore the hypothesis that pH may influence RP-1
interactions with the study lipids, a detailed structure analysis was
performed comparing the present molecular dynamics data and
prior NMR data. Amino acid side chain conformations of RP-1
in POPE/POPG or POPC/CHO in conditions approximating
pH 5.5 or 7.5 were compared with those of previous NMR
studies of the peptide in membrane mimic micelles (pH 5.0; [10])
are shown in Table 4. Amino acid side chain orientations in
SDS and anionic lipids were similar. However, side chain
orientations in mammalian membrane lipid bilayers were distinct
from those of zwitterionic DPC, suggesting the degree of peptide
interaction with the POPC:CHO ensembles was different from
that with the micelles in the NMR studies. Thus, the present data
are consistent with prior NMR findings suggesting that pH may
influence RP-1 side chain interactions, particularly in the
bacterial lipid system, potentially contributing to context-specific
efficacy.
Figure 2. Structure and biophysical properties of RP-1. (A) Ribbon and space-filling representations of RP-1. Charge: blue, basic (Arg, Lys)
cationic residues. Amphipathicity: Kyte-Doolittle hydropathy plot; brown, most hydrophobic; green intermediate; blue most hydrophilic. Molecular
imaging by Chimera [52]. (B) Helical wheel representation with polar angle subtended by hydrophilic residues as indicated.
doi:10.1371/journal.pone.0026727.g002
Table 3. RP-1 interaction with lipid systems by quantitative FTIR spectroscopy.
Lipid System pH % Conformation Tilt Angle H KA (M
21) KD (M)
a-helix loop-turn b-sheet disordered
POPE:POPG 7.5 51.5 31.6 6.5 10.4 51u 5.36104 1.261027
POPE:POPG 5.5 50.2 32.9 8.7 8.2 46u 1.36104 9.261028
POPC:CHO 7.5 42.9 33.8 13.2 10.1 34u 0.36104 5.361027
POPC:CHO 5.5 40.2 34.2 14.9 10.7 31u 0.16104 ND
The secondary structure and orientation of RP-1 was determined using representative bacterial (POPE/POPG; mole ratio 3:1) and eukaryotic (POPC/cholesterol; mole
ratio 1.2:1) mimetic liposomal systems. For conformation assessment lipid-peptide films were dispersed in deuterated buffer (10 mM PIPES pH 5.5 or 10 mM HEPES
pH 7.5) and FTIR spectra of the samples were averaged for 256 scans at a gain of 4 and a resolution of 2 cm21. The relative amounts of a-helix, b-turn, b-sheet, and
random (disordered) structures were estimated by Fourier self-deconvolution and the tabulated results represent means from four independent and highly
reproducible determinations for each environment SE 5%, or better. Kassoc was measured by introducing RP-1 to solutions containing large unilamellar vesicles (10 mM
PIPES pH 5.5 or 10 mM HEPES pH 7.5). The orientation of the RP-1 peptide in the lipid bilayer of eukaryotic and bacterial membrane mimetic systems was determined
using polarization (0u to 90u) to determine the insertion, or tilt angle of the peptide helical axis in the lipid multilayers. The binding of the peptide to lipid was expressed
as an association constant Kassoc [1], where [P] is the molar concentration of RP-1 peptide in solution, [L] is the molar concentration of lipid and [PL] is the molar
concentration of peptide bound to lipid [39].
doi:10.1371/journal.pone.0026727.t003
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Discussion
Host defense peptides are expressed in highly diverse anatomic
and physiologic niches. Such expression is hypothesized to
concatenate structure and function of a given peptide in-context
to optimize efficacy against cognate pathogens. This concept is has
been termed immunorelativity of host defense peptides [6].
Moreover, to have potential utility as anti-infective therapeutics,
native or synthetic peptides must selectively function against target
pathogens in context of infection without concomitant host
cytotoxicity. An important barrier to development of novel anti-
infective peptides has been suboptimal efficacy, durability, or
toxicity in relevant host context. Thus, it is highly significant to
define context-specific and pathogen selective toxicity and
mechanisms of action of host defense peptides or synthetic
congeners thereof.
Figure 4. Molecular dynamic simulation of RP-1 interactions with representative bacterial versus eukaryotic lipid systems at pH 7.5
and 5.5. RP-1 was docked onto the polar head group domain of a pre-equilibriated POPE:POPG (3:1, mole:mole) bilayer, or POPC:CHO (1:1,
mole:mole) with Hyperchem 7.5. Pre-run dynamics were carried out for 20 psec at 311 K, followed by 10 nsec of molecular dynamics at 311 K.
Molecular model structures were rendered using PyMOL v0.99 (http://www.pymol.org).
doi:10.1371/journal.pone.0026727.g004
Figure 3. SPR analysis of RP-1 membrane interactions using bacterial and eukaryotic membrane mimetic systems. (A) Response units
for association of RP-1 with POPE:POPG (3:1) or POPC:CHO (1.2:1) immobilized lipid multilayers at pH 5.5. Note: SPR was not detectable for the
POPC:CHO system at pH 5.5. (B) SPR data for RP-1 interaction with the membrane systems described above at pH 7.5.
doi:10.1371/journal.pone.0026727.g003
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Our prior studies have demonstrated RP-1 to exert rapid and
potent microbicidal activities, with significantly greater efficacy in
blood and blood matrices than in artificial media [12]. In contrast
to many classical antimicrobial peptides, RP-1 has striking
antimicrobial efficacy when administered intravenously in rigorous
models of infection in vivo. For example, systemic RP-1 is highly
efficacious alone or in combination with vancomycin in a murine
model of 7 d-established S. aureus catheter biofilm infection [13].
Hence, RP-1 sufficiently differentiates between pathogen and host
cell targets to achieve systemic efficacy without concomitant
toxicity.
In the present investigation, pH- and target organism-specific
efficacy, mechanisms of action, and lipid interactions of RP-1 were
compared in prototypic Gram-positive and Gram-negative
bacterial, and fungal pathogens, or mimetic systems representing
prokaryotic and eukaryotic lipid contexts. Based on highly
concordant results from integrative and complementary approach-
es, the current data indicate that pH- and/or target-specific
contexts mediate peptide efficacy and mechanisms of action
against respective microbial versus host cell targets. These
outcomes suggest that pH and cellular lipid environments may
induce subtle changes in peptide structure-function relationships
resulting in robust effects favoring peptide interactions with
pathogen rather than host cells.
A goal of the present FTIR studies was to assess if there were
any gross conformational changes in RP-1 structure as influenced
by lipid and/or pH context that may reflect a global conforma-
tional propensity. If such changes occurred, they might readily
explain differences in RP-1 binding to lipids, or distinct
antimicrobial effects at different pH. FTIR suggested modest yet
detectable changes in peptide conformations in distinct mem-
brane-like and pH contexts. In addition, a more detailed
comparison of prior NMR [10] and current FTIR data was
performed using molecular dynamics (Table 4). Prior solution
NMR was conducted on a residue specific basis to compare RP-1
backbone trajectories in micelles (SDS, bacterial mimic system; or
DPC, mammalian mimic system). In the current study, FTIR was
used to evaluate RP-1 conformation in multilayer films. Results
observed herein are consistent with prior NMR studies, providing
a basis for the hypothesis that side chain conformations of RP-1
differ in bacterial vs. mammalian lipid context. If so, subtle
variations in side chain conformation may be influenced by target
lipid composition and pH, contributing to antimicrobial specificity
and efficacy of RP-1.
Overall, microbial target, lipid membrane environment, and
pH each contributed to RP-1 structure efficacy relationships. For
example, prokaryotic versus eukaryotic lipid components had a
discernable impact on overall peptide conformation. These data
should be considered in context, recognizing that NMR and other
methods have limitations regarding structural resolution of helical
termini. RP-1 was determined to be more helical in prokaryotic
bacterial lipid systems (anionic), than in zwitterionic eukaryotic
lipid environments [10]. Further, RP-1 interactions were signifi-
cantly stronger for bacterial rather than eukaryotic lipid systems.
By comparison, the overall influence of pH on RP-1 structure-
activity relationships appeared to be more complex. In molecular
dynamic simulations, a reduction in pH from 7.5 to 5.5 decreased
the angle of penetration in bacterial lipids. These findings
corroborate the findings that RP-1 was more efficacious against
bacteria at pH 7.5. However, pH did not appear to have a
significant impact on the physicochemistry of RP-1 overall. These
results suggest two additional possibilities for future investigation:
Table 4. Comparison of RP-1 side chain conformations in membrane mimic environments using SCit side chain analysis.
ResidueNumber SDS (pH 5.0)
POPE/POPG RP-1
(pH 5.5)
POPE/POPG RP-1
(pH 7.5) DPC (pH 5.0)
POPC/CHO RP-1
(pH 5.5)
POPC/CHO RP-1
(pH 7.5)
Chi1 Chi2 Chi1 Chi2 Chi1 Chi2 Chi1 Chi2 Chi1 Chi2 Chi1 Chi2
1 ALA NV NV NV NV NV NV NV NV NV NV NV NV
2 LEU 29.8 122.1 29.6 122.1 2131.5 175.9 34.2 113.7 2144.6 2179.6 2144.6 2179.6
3 TYR 45.9 23.5 45.9 23.5 277.8 105.3 58.6 70.0 2165.6 85.7 2165.6 85.7
4 LYS 60.4 2106.7 60.9 2106.3 50.2 2169.5 62.0 2104.2 2104.3 275.3 2104.3 275.3
5 LYS 148.6 2159.3 148.2 2159.8 259.8 108.2 75.4 2143.8 260.4 171.2 260.4 171.2
6 PHE 255.1 21.4 255.1 21.5 271.9 2108.1 70.4 51.2 256.9 284.8 256.9 284.8
7 LYS 83.6 92.6 83.6 92.6 267.2 2179.9 172.9 2124.8 282.5 176.8 282.5 176.8
8 LYS 116.5 2111.2 116.2 2111.4 269.6 152.2 2103.2 2116.7 2140.0 81.4 2140.0 81.4
9 LYS 145.1 96.6 145.1 96.6 283.9 260.2 265.0 129.0 271.7 279.8 271.7 279.8
10 LEU 2157.4 111.5 2157.4 111.5 262.0 177.6 251.0 251.0 297.0 81.6 297.0 81.6
11 LEU 92.3 81.1 92.3 81.1 2177.5 50.2 250.4 177.2 278.0 168.6 278.0 168.6
12 LYS 141.1 2105.5 141.1 2105.5 49.3 2179.8 113.8 2128.0 259.0 273.7 259.0 273.7
13 SER 223.0 NV 223.0 NV 67.8 NV 170.7 NV 259.2 NV 259.2 NV
14 LEU 152.8 134.3 152.8 134.3 258.4 172.6 126.0 142.5 290.0 257.8 290.0 257.8
15 LYS 170.9 123.1 170.9 123.1 291.4 257.8 2179.9 285.9 2154.9 2135.8 2154.9 2135.8
16 ARG 130.3 66.0 2130.3 266.0 271.8 179.0 2175.3 34.2 283.9 2172.9 283.9 2172.9
17 LEU 68.9 83.4 68.9 83.4 277.0 174.0 100.9 94.5 271.6 2162.5 271.6 2162.5
18 GLY NV NV NV NV NV NV NV NV NV NV NV NV
SDS and DPC estimates are derived from previously defined NMR structures (PDB accession codes 2RLH or 2RLG; pH 5.0 [10]). In the present studies, RP-1 side chain
conformations were in simulated POPE/POPG and POPC/CHO lipid environments approximating protonating (pH 5.5) or non-protonating (pH 7.5) conditions. NV, no
consistent value.
doi:10.1371/journal.pone.0026727.t004
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1) pH may cause subtle changes in side chain orientation that
translates to different RP-1 efficacy as a function of pH [10]; and
2) pH may affect target organisms in such a way as to alter
susceptibility to RP-1. In either case, the present findings support
the view that efficacy of RP-1 and like peptides is a collective result
of intrinsic structural and functional optimization in context of
organism-specific targets and the microenvironment in which the
two interact.
The Gram-negative ST strains used in the current studies differ
in susceptibility to defensin family antimicrobial peptides [14]. The
genetic deficiency in STS results from inactivation of the gene
encoding the transcriptional regulator PhoP. PhoP disruption
voids multiple transcriptionally-induced peptide resistance mech-
anisms, including protease elaboration and differences in mem-
brane DY [2]. Interestingly, the current data revealed RP-1-
induced hyperpolarization of the ST strains, which was somewhat
greater at pH 5.5. Although not a main focus of this study, peptide
induced hyperpolarization has also been observed for the
antifungal peptides PAF [15] and Rs-AFP2 [16]. In general, the
current studies also suggested that RP-1 permeabilized and
inactivated the sensitive STS strain to greater degree than its
resistant counterpart. Such observations suggest mechanisms of a-
helical peptides such as RP-1 may not be differentiated by the STS
vs. STR phenotypes, but are influenced by pH.
In Gram-positive SA organisms, RP-1 also had significantly
greater efficacy at pH 7.5 versus 5.5. Equivalent efficacy was seen
against the SAS and SAR strains at pH 7.5, but significant
differences found at pH 5.5. Interestingly, RP-1 induced signifi-
cant depolarization of both SA strains at pH 5.5 and 7.5. In
contrast, little or no membrane permeabilization of SA was caused
by RP-1 against either strain in 1 hr. Xiong et al. previously
demonstrated that RP-1 is able to permeabilize SA after 2 h of
exposure [17]. Together, these findings agree with a temporal
process of RP-1 interaction with SA, in which initial membrane
interactions lead to rapid dissipation of DY, which precedes MP.
This scenario is entirely consistent with RP-1 inhibition of electron
transport [9], induction of a selectively permeable channel or pore,
inhibition of intracellular targets [17], or other perturbations of the
cell membrane without overt disruption of its lipid bilayer.
Resolving specific mechanisms of RP-1 action and selective
toxicity is a focus of ongoing studies. However, the current data
point to the initial interaction between RP-1 and SA, as influenced
by strain phenotype and context factors such as pH, as being
integral to selective targeting and ensuing efficacy.
Comparative efficacy and mechanisms of action in the
eukaryotic pathogen CA was of direct relevance to the hypothesis
that pH and lipid context impact RP-1 selective toxicity. In
contrast to bacteria, RP-1 exerted greater anti-fungal efficacy at
pH 5.5 than 7.5. The CA strains used in this study differ in
expression of the SSD1 gene product [18]. While its precise role in
peptide resistance is under investigation, SSD1 hyper-expression is
thought to confer resistance to certain host defense peptides
through altered CA envelope structure and mitochondrial
protection. We previously found depolarization can precede later
increases in phosphatidylserine accessibility during apoptotic-like
killing by host defense peptides in C. albicans [19]. Thus, the
fungicidal consequences of RP-1 are governed by events
subsequent to initial cell membrane interactions, including access
to and inhibition of fungal mitochondria. Supporting this concept,
Helmerhorst et al [20], Gyurko et al [21], and Jang et al [22] have
shown certain host defense peptides to enter CA species and
inhibit crucial intracellular targets, including mitochondria.
Biophysical experiments demonstrated the phospholipid context
to have a significant impact on RP-1 conformation, angle of
penetration, and kinetic interactions with respective target lipids.
Concordant FTIR, UV spectroscopy, SPR, and molecular
dynamics data indicate RP-1 exhibits highest affinity for anionic
bacterial lipids, with corresponding KA (5.3610
4 M21) and KD
(1.1561027 M) values, respectively. In this context, particularly at
pH 7.5, RP-1 assumes a highly-ordered helical conformation. In
contrast, in the eukaryotic zwitterionic lipid system, RP-1 assumes
a largely random coil structure. Furthermore, RP-1 penetration
into LUVs was significantly less in eukaryotic lipids as compared
with prokaryotic systems. Observed reductions in peptide helicity
and degree of penetration were corroborated by reduced
associations of RP-1 with eukaryotic lipids as determined by
FTIR and SPR. For example, the KA was approximately 10-fold
lower for eukaryotic versus prokaryotic lipid systems (Table 3).
Similarly, RP-1 KD was weak (pH 7.5) or undetectable (pH 5.5) in
the presence of eukaryotic membrane mimetics. These data are
highly consistent with our prior findings using NMR [10], and are
consistent with efficacy results in the current study. Together,
these observations support the hypothesis that RP-1 preferentially
targets prokaryotic and mitochondrial membranes, where it adopts
a well-ordered helix and penetrates into the bilayer in a pH
dependent manner.
Prevailing models of amphipathic a-helical peptide mechanisms
of action begin with the cationic antimicrobial peptide interacting
with the anionic bacterial surface [2,23]. Electrostatic affinity
derives from intrinsic cationic charge from the peptide primary
structure, and a composite of the electronegative phospholipid
membrane composition and DY of a target organism. For
example, bacteria typically have more electronegative lipid
composition (e.g. POPG and cardiolipin) than mammalian-like
cell membranes. Thus, DY of 2120 mV to 2150 mV are
commonly seen in bacterial and mitochondrial membranes,
whereas 260 mV to 280 mV are typical of eukaryotic cell
membranes [2,24]. In this model, RP-1 would initially have a
relatively disordered conformation in aqueous environments prior
to interaction with the anionic bacterial surface [2]. Only in
context of prokaryotic lipid environments does such a peptide
adopt a highly-ordered helical conformation, with an obtuse polar
angle. These events may drive penetration and permeabilization of
the membrane, dissipate DY, and ultimately result in massive de-
energization or alternative mechanisms that lead to the eventual
death of the bacterium [2,23].
Current findings also shed new light on RP-1 interactions with
and mechanisms of action against fungi. For example, RP-1
exerted anti-CA activity with a pH optimum of 5.5. These findings
are consistent with the antifungal properties of a-helical peptides
from other human kinocidins, such as human IL-8 [25].
Interestingly, RP-1 caused significant permeabilization, but only
modest de-energization of CA, within the assay period. Moreover,
all experimental measures of RP-1 interaction with eukaryotic
lipids suggested minimal affinity or interaction at pH 5.5. These
intriguing data suggest several possibilities for future investigation.
For example, specific membrane constituents in CA (e.g.
ergosterol) may uniquely influence RP-1 interactions to supersede
predictions made using phosphatidylcholine and cholesterol
(POPC:CHO). This model is consistent with RP-1 permeabiliza-
tion of the CA cell membrane, without significant membrane
penetration [26]. Alternatively, RP-1 may rapidly permeabilize
and penetrate the CA cell membrane, for eventual targeting of the
fungal mitochondrion. Although the current studies did not detect
significant DY dissipation by RP-1 in 1 h, our previous studies
showed that RP-1 or other peptides significantly de-energize the
CA mitochondrion at 2 h [8,22]. Hence, the kinetic mechanisms
of RP-1 may initially permeabilize the CA membrane as a means
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for the peptide to access and preferentially target the mitochondria
within. Lastly, it is possible that the models used in the present
studies limit further differentiation of eukaryotic rather than
prokaryotic pathogen membranes. For example, while the
zwitterionic membrane mimetic system employed herein reflects
eukaryotic themes, it is more similar to mammalian rather than
fungal lipid bilayers [2].
Finally, it is important to consider the potential indirect effects
of pH on efficacy of RP-1 or other peptides. For example, it is
likely that pH contributes to peptide susceptibility or resistance
pathways of the target organisms themselves. For example, mild
acidic conditions can induce stress response pathways in several
bacterial and fungal pathogens [27,28,29]. In some cases, response
to pH alters peptide susceptibility [8]. Alternatively, pH may have
distinct effects on efficacy of different host defense peptides. For
example, pH-influenced susceptibility to defensin-like peptides
may be distinct from those of a-helical peptides such as RP-1. This
concept would enable greater host defense coverage in dynamic
physiologic and microbiologic contexts.
It is also important to consider the methodologic constraints of
the current studies. In the prior NMR evaluation, RP-1 backbone
trajectory and side chain conformations were evaluated at pH 5.0
in micelles. While it is possible to assess RP-1 structure by NMR at
neutral or basic pH, amide H/D exchange is typically protein-
specific. Thus, in more disordered proteins — where amide
hydrogens are not H-bonded — exchange can occur more readily,
whereas proteins with strong helical or sheet propensities have
slower H/D exchange due to extensive N-H…O = C H-bonding.
For this reason, RP-1 and like helical peptides are preferably
analyzed at lower pH. The fact that RP-1 did not exhibit strong
HN signals in solution NMR at higher pH [10] affirms this
concept. While beyond the scope of the present studies, such areas
of investigation will likely contribute to a more complete
understanding of host defense peptide structure-activity relation-
ships.
In summary, the present results suggest that pH- and lipid-
specific contexts mediate selective toxicity of antimicrobial peptide
RP-1. These findings support the hypothesis that peptides such as
RP-1 exert selective or optimal toxicity against microbial
pathogens rather than host cells in relevant microenvironmental
context. This interpretation is consistent with the concept of host
defense peptide immunorelativity (AEGIS model), in which
molecular defenses concatenate peptide structure-function rela-
tionships corresponding to anatomic or physiologic sites or
conditions to optimize efficacy against cognate organisms therein
[6].
Materials and Methods
Microorganisms
A panel of microorganisms comprising prototypic Gram-
positive, Gram-negative, and fungal human pathogens was
investigated. Staphylococcus aureus (SA) strains ISP479C (peptide-
susceptible; [SAS]) and ISP479R (peptide-resistant [SAR]) exhibit
distinct susceptibilities to human host defense peptides in vitro (e.g.
platelet kinocidins [9]). Relative to parental strain ISP479C, the
ISP479R strain has a mutation in the snoD gene which encodes the
complex I NADH-ubiquinone oxidoreductase. Disruption of this
gene leads to a reduced membrane potential and increased
resistance to cationic antimicrobial peptides. Salmonella typhimurium
(ST) strain 5996s (peptide-sensitive; [STs]) and ATCC strain
14028 (peptide-resistant; [STR]) is resistant to human defensin
HNP-1 in vitro, and is hypervirulent in murine models of infection
[14]. Likewise, Candida albicans (CA) strain 36082S (peptide-
susceptible; [CAS]) is a human clinical isolate, while strain
36082R (peptide-resistant; [CAR]) is derived from 36082S [30]
and differs in expression of the SSD1 corresponding to its peptide
resistance phenotype [6]. Respective strains have otherwise
equivalent genotypes and growth characteristics. All organisms
were cultured to logarithmic phase in brain heart infusion broth
(BHI) at 37uC (SA or ST) or 30uC (CA). Cells were harvested,
washed, and briefly sonicated to assure singlet organisms.
Organisms were quantified by spectrophotometry and adjusted
to 16106 CFU in buffers as appropriate to specific experiments
(see below).
Antimicrobial Peptide RP-1
RP-1 is a synthetic antimicrobial peptide engineered based in-
part on C-terminal microbicidal helices of platelet factor-4 (PF-4;
CXCL4) family kinocidins from humans and other mammals
[31,32]. Our prior studies have demonstrated this domain
manifests much of the direct microbicidal activity of kinocidins,
recapitulating or exceeding the antimicrobial efficacy of respective
holoproteins [25,32]. RP-1 is comprised of 18 naturally occurring
amino acid residues (MW, 2162.8) and has an isoelectric point (pI)
of 10.8. Our previous NMR studies have substantiated that RP-1
has a highly-ordered a-helical conformation, particularly in
context of bacterial lipid systems [10]. Mean hydrophobic moment
(MH) and hydrophobicity of RP-1 were quantified using a
consensus hydrophobicity scale (www.bbcm.univ.trieste.it/
,tossi/HydroCalc), and its polar angle was determined using
the Zidovetski method [33]. The potential affect of pH 5.5 versus
7.5 on net 3-dimensional conformation of RP-1 was assessed using
the computational prediction of protonation software H++
(http://biophysics.cs.vt.edu/H++/index.php).
Comparative Antimicrobial Efficacy of RP-1
RP-1 efficacy against study organisms was evaluated using
radial diffusion at pH 5.5 or 7.5 [1,34]. In brief, logarithmic-phase
organisms were inoculated (106 CFU/ml) into buffered agarose
(10 mM MES, pH 5.5 or 10 mM PIPES, pH 7.5), and poured
into plates. Peptides (10 mg/well) were introduced into wells in the
seeded matrix, and incubated for 3 h at 37uC. After overlay of
nutrient medium, assays were incubated at 37uC or 30uC for
bacteria or fungi, respectively. Zones of inhibition were measured
at 24 h as the radius (mm) of complete or partial clearance
subtracting the well radius. Independent experiments were
repeated a minimum of two times.
Comparative Mechanisms of RP-1 Action
Flow cytometry was used to measure two mechanisms of RP-1
action at pH 5.5 and 7.5: 1) MP; and 2) de-energization as
measured by DY of bacterial cell membranes or fungal
mitochondria. A FACSCaliburH instrument (Beckton Dickinson)
was used to detect the following assay fluorophores: propidium
iodide (PI; Ex535 nm/Em620 nm; Sigma, St. Louis, MO) to assess
MP; and 3,3-dipentyloxacarbocyanine (DiOC5; Ex484 nm/
Em500 nm; Invitrogen, Carlsbad, CA) to assess DY. For experi-
ments, 26107 cells were incubated with peptide (10 mg/ml) in
1 ml of 10 mM PIPES (pH 7.5) or 10 mM MES (pH 5.5) for
either 5, 30 or 60 min with shaking at 30uC (C. albicans) or 37uC
(bacteria). At indicated time points, a stain buffer was added
(DiOC5, 0.5 mM plus PI, 5.0 mg/ml, in 50 mM potassium-
containing MEM (K+MEM; without phenol red, pH 7.2; Sigma).
Cells were allowed to stain at room temperature for 15 min prior
to analysis. Experiments included control cells exposed to well-
established perturbants of MP (70% EtOH), DY (CCCP;
100 mM; Sigma), or K+MEM buffer alone. Flow cytometry was
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performed at 20uC in 10 mM K+MEM, with forward light scatter
(FSC) data collected to ensure fluorescence was not an artifact of
aggregation. The validity of these methods to assess MP or DY
approaches the reliability of classical patch clamp methods
[35,36,37]. For each study, the fluorescence from a minimum of
5,000 cells was acquired and plotted against FSC. Results from a
minimum of two independent experiments done on different days
were included in statistical analyses.
RP-1 Binding to Membrane-Mimetic Liposomes
RP-1 interactions with membrane mimetic liposomes was
determined by introducing peptide to solution-phase large LUVs
in 10 mM PIPES (pH 5.5) or 10 mM HEPES (pH 7.5).
Liposomes of palmitoyoleoyl-phosphatidylethanolamine and pal-
mitoyloleoyl-phosphatidylglycerol (POPE / POPG, mole ratio of
3:1) simulated the bacterial inner membrane. By comparison,
liposomes of POPE-phosphatidylcholine and cholesterol (POPC /
CHO, mole ratio 1.2:1) simulated eukaryotic lipid membrane
systems [11]. RP-1-liposome solutions were incubated by shaking
for one hour at 25uC to reach equilibrium. The liposome-peptide
solution was centrifuged at 100,0006g (30 min; Beckman Airfuge)
to isolate liposomes with bound peptide. Concentration of RP-1 in
lipid and aqueous phases was determined by transmission UV
spectroscopy integrating a molar extinction coefficient of
1280 M21 cm21 for RP-1 at 280 nm [38]. Solution phase
measurements were made directly in supernatant, whereas the
lipid-peptide pellet was dispersed in 20 mM SDS-buffer to ensure
optical clarity for UV spectroscopy. Peptide-to-lipid binding was
expressed as an association constant Ka, where [P] is molar
concentration of RP-1 peptide in solution, [L] is the molar
concentration of lipid, and [PL] is the molar concentration of
peptide bound to lipid [39], as indicated in equation [1], below:
Ka~ PL½ = P½  L½  ð1Þ
Kinetic Assessment of RP-1-Lipid Interactions by Surface
Plasmon Resonance
The kinetics of RP-1 interactions with lipid bilayers simulating
bacterial versus eukaryotic membrane ensembles were evaluated
by surface plasmon resonance (SPR) spectroscopy using a Biacore
3000 system (Biacore, Uppsala, Sweden). Liposomes (prepared as
above) were deposited by drying lipid films from chloroform under
high vacuum (12 h). Lipid films were then dispersed in PBS
(pH 7.4) by vortexing and sonication to give a final lipid
concentration of 20 mM. This suspension was extruded twenty
times using a mini-extruder (1 mm polycarbonate filter; Avanti
Polar Lipids, Alabaster, AL) to yield small unilamellar vesicles
(SUV). Resulting SUV liposomes were deposited (rate, 2 ml/min)
onto the surface of an L1 biosensor chip, forming lipid multilayers
which were washed (10 mM NaOH at 10 ml/min) to ensure
uniform lipid ensembles. For interaction kinetics, the running
buffer was 50 mM Tris, 50 mM malate, and 150 mM NaCl
adjusted to pH 5.5 [MES] or 7.5 [PIPES]. RP-1 interactions with
lipid ensembles were determined by injecting samples at 50 ml/
min for a 3 min association phase and a 3 min dissociation phase,
each at 37uC. Binding affinities of RP-1 to the lipid multilayers
were assessed by analysis of the SPR sensorgrams, with response
units (RU) plotted as a function of time. Resulting sensorgrams
were analyzed by BIAevaluation software (version 4.1) for curve
fitting to determine mean on- and off-rate constants (Kon and Koff)
and dissociation constant (Kd = Koff/Kon) from measurements
made at 1 mg RP-1/ml of buffer.
RP-1 Conformation and Orientation in Membrane
Mimetic Liposomes
The secondary structures and orientations of RP-1 were assessed
in two distinct membrane mimetic liposomal systems that reflect the
predominant lipids comprising bacterial versus eukaryotic mem-
brane contexts [11]. Dispersions containing anionic lipid (POPE/
POPG; mole ratio, 3:1) emulated the bacterial membrane, while
neutral lipid mixtures of POPC/cholesterol (mole ratio 1.2:1)
simulated eukaryotic membranes. The RP-1 peptide in ethanol was
co-solvated with lipid systems in cholorform (ethanol:choloroform,
1:1, v:v), followed by vacuum (10 mTorr) solvent removal under
nitrogen. Resulting lipid-peptide films were dispersed in deuterated
buffer (10 mM PIPES, pH 5.5 or 10 mM HEPES, pH 7.5) by
vortex and repeated freeze-thaw cycles to obtain large unilamellar
vesicles. Lipid-peptide samples were isolated by centrifugation
(100,0006 g; Beckman Airfuge TM). Pellets were re-suspended in
200 ml of deuterated water and transferred onto a germanium
attenuated reflectance (ATR) crystal (5062062 mm; 45u; Pike
Technologies, Madison, WI) to produce lipid-peptide films. Lipid-
peptide matrices were then exposed to deuterium vapor to yield
films$35% hydrated [40]. Infrared spectra were measured using a
Bruker Vector FTIR spectrometer equipped with a deuterated
triglycine sulfate detector (25uC). Resulting FTIR spectra were
averaged for 256 scans at a gain of 4 and a resolution of 2 cm21.
Relative amounts of a-helix, b-turn, b-sheet, or random (disordered)
structures were estimated using Fourier self-deconvolution
(GRAMS/AI8, version 8.0, Thermo Electron Corp, Waltham,
MA) and area of component peaks calculated using curve-fitting
software (Igor Pro, version 1.6, Wavemetrics, Lake Oswego, OR)
[41]. FTIR frequency limits were: a-helix (1662–1645 cm21), b-
sheet (1637–1613 and 1710–1682 cm21), turn/bend (1682–
1662 cm21), and disordered or random (1650–1637 cm21) [42].
To estimate the orientation of RP-1 in prokaryotic or eukaryotic
membrane mimetics, gold wire polarizers (Perkin Elmer, Wal-
tham, MA) were rotated from 0u–90u to obtain polarized IR
spectra of each lipid-peptide film [43]. The insertion (or tilt) angle
of RP-1 helical axes in the lipid multilayers was calculated based
on the ratio RATR = AI/A) , with areas of absorbance at 0u and
90u polarizations for the amide I band centered at 1656 cm21.
These measures assumed a thick film approximation with the
values for the electric field components of the evanescent wave to
be Ex = 1.398, Ey = 1.516, Ez = 1.625, and an angle a= 39u for
vibrational dipole relative to the molecular axis of the helix to
derive an order parameter, S in equation [2], below [44]. The
helical tilt angle, H was then derived from the order parameter
using equation [3], below [44].
S~ Ex2{RATR Ey2zEz2

Ex2{RATR Ey2{2 Ez2
 
3 cos2 2a{1

2
 {1 ð2Þ
S~ 3Scos 2 HT{1ð Þ=2 ð3Þ
Comparative Molecular Dynamics of RP-1 Interaction
with Lipid Mimetic Systems
Computational studies of RP-1 interactions with lipid systems
were conducted using GROMACS version 4.5.4 suite of
½ 
½ 
½ 
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molecular dynamics software [45]. Lowest energy atomic
coordinates for RP-1 within SDS micelles (PDB accession code
2RLG; pH 5.0) were used as a starting structure within bacterial
lipid environments, whereas the lowest energy conformer of RP-1
in DPC micelles (PDB accession code 2RLH; pH 5.0) was used as
starting structure for simulated mammalian membranes [10].
Structural files for POPE, POPG, and POPC were accessed via
the Tieleman website (http://moose.bio.ucalgary.ca). POPC
parameters for the ffG53a6 force field were downloaded from
(http://compbio.biosci.uq.edu.au/atb/) and POPE parameters
were derived from conversion of POPC parent files to POPE
values [46]. Topographies for POPG were those of Kukol [47].
Structure and parameter files for cholesterol were accessed
through the ATB database (http://compbio.biosci.uq.edu.au/
atb).
RP-1 peptide was initially docked onto the polar head group
domain of pre-equilibriated POPE:POPG (3:1, mole:mole) or
POPC:CHO (1:1, mole:mole) bilayers using Hyperchem (Gains-
ville, FL; version 7.52) with the CHARMM27 force field option
[10,48,49]. The resulting ensemble was placed in a 656656100 A˚
periodic simulation box, solvated with SPC water and neutralized
by appropriate counter ions. RP-1-lipid ensembles were optimized
by lateral translation for molecular packing of lipids and peptide
using established Perl script function, INFLATEGRO (http://
moose.bio.ucalgary.ca/). Since there is no direct way to explicitly
adjust the pH in the Gromacs force field environment, pdb2gmx
(implementing the –lys option) was used to alter the degree of
protonation of the lysine side chains to emulate differences in pH in
the simulations [50]. Optimal lipid bilayer-peptide ensembles were
then refined using Polak-Ribiere conjugate gradient minimization,
and the systems were solvated by constraining the peptide over
20 psec of pre-run dynamics at 311 K. Pre-dynamics were followed
by 50 nsec of molecular dynamics at 311 degrees K utilizing the
ffG53a6 force field option (GROMACS) without constraints to
achieve thermodynamically reasonable approximation of equilibri-
um structure for a given construct in each lipid bilayer system.
Model structures for molecular graphics figures were rendered using
PyMOL (version 0.99; http://www.pymol.org). The comparison of
side chain conformations of simulated versus NMR peptide
structures in various environments were analyzed using SCit
(http://bioserv.rpbs.jussieu.fr/cgi-bin/SCit; [51]).
Statistical Analysis
Differences in experimental outcomes were compared by
student t or chi2 test as appropriate for specific data sets.
Bonferroni correction was applied as appropriate for non-
parametric data. P values#0.05 (95%) were considered significant.
Supporting Information
Figure S1 Quantitative analysis of RP-1 on membrane
energetics (DiOC5) and membrane permeabilization
(PI) in ST, SA and CA. Data are normalized to stained control
cell fluorescence and expressed as percent of control (dashed line is
equivalent to 100%). Time points: 5, 30 and 60 min. Data shown
represent exposure to either ethanol (yellow), CCCP (red) or RP-1
(blue). Data represent mean 6 one standard deviation for a
minimum of two independent experiments. Statistical significance
(P,0.05) indicated by asterisk. Data were generated using FCS
Express software (version 3.0; De Novo; Los Angeles, CA).
(TIF)
Figure S2 Secondary structure estimation as measured
by FTIR spectroscopy. Relative amounts of a-helix, b-turn, b-
sheet, or random (disordered) structures were estimated by Fourier
self-deconvolution (GRAMS/AI8, version 8.0, Thermo Electron
Corp, Waltham, MA) and area calculations of component peaks
calculated with curve fitting software (Igor Pro, version 1.6,
Wavemetrics, Lake Oswego, OR). The FTIR frequency limits
used for structures were: a-helix (1662–1645 cm21), b-sheet
(1637–1613 and 1710–1682 cm21), turn/bend (1682–
1662 cm21), and disordered or random (1650–1637 cm21).
(TIF)
Table S1 Differences in experimental outcomes were
compared by student t test. P values#0.05 (95%) were
considered to be significant and are indicated in red.
(DOC)
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